NCT06451276

Brief Summary

The present study will compare the effectiveness of adhesive nasoalveolar molding (GS-NAM) and conventional nasoalveolar molding on the alveolar ridge, nasal, and labial growth in children with unilateral cleft lip and palate. objectives: -

  1. 1.Evaluation of the anatomical position of the greater and lesser segments of the maxilla related to a stable midline anatomical point.
  2. 2.Evaluation of the nasal symmetry.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
30

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Jul 2024

Geographic Reach
1 country

2 active sites

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 31, 2024

Completed
11 days until next milestone

First Posted

Study publicly available on registry

June 11, 2024

Completed
1 month until next milestone

Study Start

First participant enrolled

July 20, 2024

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 20, 2025

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

August 20, 2025

Completed
Last Updated

June 11, 2024

Status Verified

June 1, 2024

Enrollment Period

1 year

First QC Date

May 31, 2024

Last Update Submit

June 10, 2024

Conditions

Outcome Measures

Primary Outcomes (5)

  • Posterior ends of alveolar crest

    width between the most posterior ends of the alveolar crest in the greater segment and lesser segment

    3 months

  • Middle ends of alveolar crest

    width between the middle parts of the cleft palate (The intersection points between the palatally extended buccal frenum sulcus line and the palatal gingival groove in the greater and lesser segment

    3 months

  • Anterior ends of alveolar crest

    The widths of the cleft gap (The anterior endpoint of the alveolar crest in the greater and lesser segment)

    3 months

  • Mid line of maxilla

    Inc-Sagittal: - Perpendicular distance from Inc point (The intersection points between the labial frenum-incisive papilla point line and the alveolar crest of the premaxilla in the greater segment) to sagittal line (The perpendicular line to the PG-PL line)

    3 months

  • Angulation of maxilla

    Mid-Inc)-Sagittal: - Angle among Inc point, midpoint in PG -PL, and sagittal line

    3 months

Secondary Outcomes (6)

  • Alar base width

    3 months

  • Columella length.

    3 months

  • Columella angle deviation.

    3 months

  • Nostril height and width on the cleft side.

    3 months

  • Nostril height and width on the non-cleft side

    3 months

  • +1 more secondary outcomes

Study Arms (3)

Adhesive nasoalveolar molding (GS-NAM)

ACTIVE COMPARATOR

3D (3 dimensional ) printed conventional NAM in thickness of 2 mm. The cleft area will be blocked in software, and NAM will be fabricated using a 3D (3 dimensional ) printer. Soft acrylic resin will be added to make pressure area and reduction in opposing for relief. The appliance will be evaluated and adjusted monthly. A nasal stent will be fabricated when the cleft is 5mm

Device: Nasoalveolar molding in unilateral cleft lip and palate

Conventional nasoalveolar molding

EXPERIMENTAL

(positive control group) comprises 10 cases of unilateral cleft lip and palate that will be scheduled for construction of 3D (3 dimensional ) printed conventional NAM in thickness of 2 mm. The cleft area will be blocked in software, and NAM will be fabricated using a 3D printer. Soft acrylic resin will be added to make pressure area and reduction in opposing for relief. The appliance will be evaluated and adjusted monthly. A nasal stent will be fabricated when the cleft is 5mm

Device: Nasoalveolar molding in unilateral cleft lip and palate

normal children

NO INTERVENTION

normal children which will be compared with groups 1 and 2 for results evaluation

Interventions

compare the effectiveness of adhesive nasoalveolar molding (GS-NAM) and conventional nasoalveolar molding on the alveolar ridge, nasal, and labial growth in children with unilateral cleft lip and palate

Also known as: NAM
Adhesive nasoalveolar molding (GS-NAM)Conventional nasoalveolar molding

Eligibility Criteria

Age7 Days - 12 Weeks
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17)

You may qualify if:

  • Age: 1- 8 weeks.
  • Gender: male and female.
  • Patients with a unilateral cleft alveolus and lip.
  • No developmental syndromes or atypical cleft pathology in medical history.
  • No previous history of unilateral CLP correction.
  • Motivated parents toward the treatment.

You may not qualify if:

  • Patients with a bilateral cleft alveolus and lip
  • Syndromic patient
  • Uncooperative caregiver

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Faculty of dental medicine

Cairo, 4050113, Egypt

Location

Faculty of Dental Medicine (Boys, Cairo), Al- Azhar University

Cairo, 4450113, Egypt

Location

MeSH Terms

Conditions

Cleft Lip

Interventions

Nasoalveolar Molding

Condition Hierarchy (Ancestors)

Lip DiseasesMouth DiseasesStomatognathic DiseasesMouth AbnormalitiesStomatognathic System AbnormalitiesCongenital AbnormalitiesCongenital, Hereditary, and Neonatal Diseases and Abnormalities

Intervention Hierarchy (Ancestors)

Preoperative CarePerioperative CarePatient CareTherapeuticsSurgical Procedures, OperativeHealth ServicesHealth Care Facilities Workforce and Services

Study Officials

  • Adel F Hassan, Phd

    Fucalty of dental medicine

    STUDY DIRECTOR

Central Study Contacts

Ahmed F Ahmed, Master

CONTACT

Adel F Hassan, Phd

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
INVESTIGATOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Doctor

Study Record Dates

First Submitted

May 31, 2024

First Posted

June 11, 2024

Study Start

July 20, 2024

Primary Completion

July 20, 2025

Study Completion

August 20, 2025

Last Updated

June 11, 2024

Record last verified: 2024-06

Data Sharing

IPD Sharing
Will share

all IPD that underlie results in a publication

Shared Documents
STUDY PROTOCOL, CSR, ANALYTIC CODE
Time Frame
4 months
Access Criteria
all IPD that underlie results in a publication
More information

Locations